p.95 抽出テキスト
692. Schlotter F, Dietz MF, Stolz L, Kresoja KP, Besler C, Sannino A, et al. Atrial functional tricuspid regurgitation: novel definition and impact on prognosis. Circ Cardiovasc Interv 2022;15:e011958. https://doi.org/10.1161/CIRCINTERVENTIONS.122.011958 693. Adamo M, Chioncel O, Pagnesi M, Bayes-Genis A, Abdelhamid M, Anker SD, et al. Epidemiology, pathophysiology, diagnosis and management of chronic right-sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC. Eur J Heart Fail 2024;26:18–33. https://doi.org/10.1002/ejhf.3106 694. Fortuni F, Dietz MF, Prihadi EA, van der Bijl P, De Ferrari GM, Knuuti J, et al. Prognostic implications of a novel algorithm to grade secondary tricuspid regurgitation. JACC Cardiovasc Imaging 2021;14:1085–95. https://doi.org/10.1016/j.jcmg.2020.12.011 695. Peri Y, Sadeh B, Sherez C, Hochstadt A, Biner S, Aviram G, et al. Quantitative assessment of effective regurgitant orifice: impact on risk stratification, and cut-off for severe and torrential tricuspid regurgitation grade. Eur Heart J Cardiovasc Imaging 2020;21: 768–76. https://doi.org/10.1093/ehjci/jez267 696. Dreyfus J, Galloo X, Taramasso M, Heitzinger G, Benfari G, Kresoja KP, et al. TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation. Eur Heart J 2024;45:586–97. https://doi.org/10.1093/eurheartj/ehad585 697. Hahn RT, Lawlor MK, Davidson CJ, Badhwar V, Sannino A, Spitzer E, et al. Tricuspid Valve Academic Research Consortium definitions for tricuspid regurgitation and trial endpoints. Eur Heart J 2023;44:4508–32. https://doi.org/10.1093/eurheartj/ehad653 698. Petersen SE, Khanji MY, Plein S, Lancellotti P, Bucciarelli-Ducci C. European Association of Cardiovascular Imaging expert consensus paper: a comprehensive review of cardiovascular magnetic resonance normal values of cardiac chamber size and aortic root in adults and recommendations for grading severity. Eur Heart J Cardiovasc Imaging 2019;20:1321–31. https://doi.org/10.1093/ehjci/jez232 699. Kawel-Boehm N, Hetzel SJ, Ambale-Venkatesh B, Captur G, Francois CJ, Jerosch-Herold M, et al. Reference ranges (“normal values”) for cardiovascular magnetic resonance (CMR) in adults and children: 2020 update. J Cardiovasc Magn Reson 2020;22:87. https://doi.org/10.1186/s12968-020-00683-3 700. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015;16: 233–70. https://doi.org/10.1093/ehjci/jev014 701. Addetia K, Miyoshi T, Citro R, Daimon M, Gutierrez Fajardo P, Kasliwal RR, et al. Two-dimensional echocardiographic right ventricular size and systolic function measurements stratified by sex, age, and ethnicity: results of the World Alliance of Societies of Echocardiography study. J Am Soc Echocardiogr 2021;34:1148–1157.e1. https://doi.org/10.1016/j.echo.2021.06.013 702. Addetia K, Miyoshi T, Amuthan V, Citro R, Daimon M, Gutierrez Fajardo P, et al. Normal values of three-dimensional right ventricular size and function measurements: results of the World Alliance Societies of Echocardiography study. J Am Soc Echocardiogr 2023;36:858–866.e1. https://doi.org/10.1016/j.echo.2023.04.011 703. Dietz MF, Prihadi EA, van der Bijl P, Goedemans L, Mertens BJA, Gursoy E, et al. Prognostic implications of right ventricular remodeling and function in patients with significant secondary tricuspid regurgitation. Circulation 2019;140:836–45. https:// doi.org/10.1161/CIRCULATIONAHA.119.039630 704. Eriksen-Volnes T, Grue JF, Hellum Olaisen S, Letnes JM, Nes B, Løvstakken L, et al. Normalized echocardiographic values from guideline-directed dedicated views for cardiac dimensions and left ventricular function. JACC Cardiovasc Imaging 2023;16: 1501–15. https://doi.org/10.1016/j.jcmg.2022.12.020 705. Lurz P, Orban M, Besler C, Braun D, Schlotter F, Noack T, et al. Clinical characteristics, diagnosis, and risk stratification of pulmonary hypertension in severe tricuspid regurgitation and implications for transcatheter tricuspid valve repair. Eur Heart J 2020;41: 2785–95. https://doi.org/10.1093/eurheartj/ehaa138 706. Stocker TJ, Hertell H, Orban M, Braun D, Rommel KP, Ruf T, et al. Cardiopulmonary hemodynamic profile predicts mortality after transcatheter tricuspid valve repair in chronic heart failure. JACC Cardiovasc Interv 2021;14:29–38. https://doi.org/10.1016/j. jcin.2020.09.033 707. Brener MI, Lurz P, Hausleiter J, Rodés-Cabau J, Fam N, Kodali SK, et al. Right ventricular-pulmonary arterial coupling and afterload reserve in patients undergoing transcatheter tricuspid valve repair. J Am Coll Cardiol 2022;79:448–61. https://doi. org/10.1016/j.jacc.2021.11.031 708. Stolz L, Weckbach LT, Karam N, Kalbacher D, Praz F, Lurz P, et al. Invasive right ventricular to pulmonary artery coupling in patients undergoing transcatheter edge-to-edge tricuspid valve repair. JACC Cardiovasc Imaging 2023;16:564–6. https:// doi.org/10.1016/j.jcmg.2022.10.004 709. Dreyfus J, Juarez-Casso F, Sala A, Carnero-Alcazar M, Eixerés-Esteve A, Bohbot Y, et al. Benefit of isolated surgical valve repair or replacement for functional tricuspid regurgitation and long-term outcomes stratified by the TRI-SCORE. Eur Heart J 2024;45: 4512–22. https://doi.org/10.1093/eurheartj/ehae578 710. Thourani VH, Bonnell L, Wyler von Ballmoos MC, Mehaffey JH, Bowdish M, Kurlansky P, et al. Outcomes of isolated tricuspid valve surgery: a Society of Thoracic Surgeons analysis and risk model. Ann Thorac Surg 2024;118:873–81. https://doi.org/10.1016/j. athoracsur.2024.04.014 711. Anguita-Gámez M, Giraldo MA, Nombela-Franco L, Eixeres Esteve A, Cuerpo G, Lopez-Menendez J, et al. Validation of the TRI-SCORE in patients undergoing surgery for isolated tricuspid regurgitation. Heart 2023;109:1401–6. https://doi.org/10.1136/ heartjnl-2022-322067 712. Nassif ME, Qintar M, Windsor SL, Jermyn R, Shavelle DM, Tang F, et al. Empagliflozin effects on pulmonary artery pressure in patients with heart failure: results from the EMBRACE-HF trial. Circulation 2021;143:1673–86. https://doi.org/10.1161/ circulationaha.120.052503 713. Sorajja P, Whisenant B, Hamid N, Naik H, Makkar R, Tadros P, et al. Transcatheter repair for patients with tricuspid regurgitation. N Engl J Med 2023;388:1833–42. https:// doi.org/10.1056/NEJMoa2300525 714. Dreyfus J, Flagiello M, Bazire B, Eggenspieler F, Viau F, Riant E, et al. Isolated tricuspid valve surgery: impact of aetiology and clinical presentation on outcomes. Eur Heart J 2020;41:4304–17. https://doi.org/10.1093/eurheartj/ehaa643 715. Scotti A, Sturla M, Granada JF, Kodali SK, Coisne A, Mangieri A, et al. Outcomes of isolated tricuspid valve replacement: a systematic review and meta-analysis of 5,316 patients from 35 studies. EuroIntervention 2022;18:840–51. https://doi.org/10.4244/EIJ-D- 22-00442 716. Chen Q, Bowdish ME, Malas J, Roach A, Gill G, Rowe G, et al. Isolated tricuspid operations: the Society of Thoracic Surgeons adult cardiac surgery database analysis. Ann Thorac Surg 2023;115:1162–70. https://doi.org/10.1016/j.athoracsur.2022.12.041 717. Hahn RT, Wilkoff BL, Kodali S, Birgersdotter-Green UM, Ailawadi G, Addetia K, et al. Managing implanted cardiac electronic devices in patients with severe tricuspid regurgitation: JACC state-of-the-art review. J Am Coll Cardiol 2024;83:2002–14. https://doi. org/10.1016/j.jacc.2024.02.045 718. Taramasso M, Gavazzoni M, Pozzoli A, Dreyfus GD, Bolling SF, George I, et al. Tricuspid regurgitation: predicting the need for intervention, procedural success, and recurrence of disease. JACC Cardiovasc Imaging 2019;12:605–21. https://doi.org/ 10.1016/j.jcmg.2018.11.034 719. Bannehr M, Edlinger CR, Kahn U, Liebchen J, Okamoto M, Hähnel V, et al. Natural course of tricuspid regurgitation and prognostic implications. Open Heart 2021;8: e001529. https://doi.org/10.1136/openhrt-2020-001529 720. Park SJ, Oh JK, Kim SO, Lee SA, Kim HJ, Lee S, et al. Determinants of clinical outcomes of surgery for isolated severe tricuspid regurgitation. Heart 2021;107:403–10. https:// doi.org/10.1136/heartjnl-2020-317715 721. McCarthy PM, Bhudia SK, Rajeswaran J, Hoercher KJ, Lytle BW, Cosgrove DM, et al. Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg 2004;127:674–85. https://doi.org/10.1016/j.jtcvs.2003.11.019 722. Kwak JJ, Kim YJ, Kim MK, Kim HK, Park JS, Kim KH, et al. Development of tricuspid regurgitation late after left-sided valve surgery: a single-center experience with longterm echocardiographic examinations. Am Heart J 2008;155:732–7. https://doi.org/ 10.1016/j.ahj.2007.11.010 723. Dreyfus GD, Corbi PJ, Chan KM, Bahrami T. Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair? Ann Thorac Surg 2005;79: 127–32. https://doi.org/10.1016/j.athoracsur.2004.06.057 724. Dreyfus GD, Essayagh B, Benfari G, Dulguerov F, Haley SR, Dommerc C, et al. Outcome of consistent guideline-based tricuspid management in patients undergoing degenerative mitral regurgitation correction. JTCVS Open 2021;7:125–38. https://doi. org/10.1016/j.xjon.2021.07.010 725. Gammie JS, Chu MWA, Falk V, Overbey JR, Moskowitz AJ, Gillinov M, et al. Concomitant tricuspid repair in patients with degenerative mitral regurgitation. N Engl J Med 2022;386:327–39. https://doi.org/10.1056/NEJMoa2115961 726. Pettinari M, De Kerchove L, Lazam S, Pasquet A, Gerber B, Vanoverschelde JL, et al. Mid-term results of a randomized trial of tricuspid annuloplasty for less-than-severe functional tricuspid regurgitation at the time of mitral valve surgery. Eur J Cardiothorac Surg 2019;55:851–8. https://doi.org/10.1093/ejcts/ezy378 727. Ailawadi G, Voisine P, Raymond S, Gelijns AC, Moskowitz AJ, Falk V, et al. Pacemaker implantation associated with tricuspid repair in the setting of mitral valve surgery: insights from a Cardiothoracic Surgical Trials Network randomized trial. J Thorac Cardiovasc Surg 2022;167:2104–16.e5. https://doi.org/10.1016/j.jtcvs.2022.11.031 728. Ragnarsson S, Taha A, Nielsen SJ, Amabile A, Geirsson A, Krane M, et al. Pacemaker implantation following tricuspid valve annuloplasty. JTCVS Open 2023;16:276–89. https://doi.org/10.1016/j.xjon.2023.08.017 729. Iribarne A, Alabbadi SH, Moskowitz AJ, Ailawadi G, Badhwar V, Gillinov M, et al. Permanent pacemaker implantation and long-term outcomes of patients undergoing concomitant mitral and tricuspid valve surgery. J Am Coll Cardiol 2024;83:1656–68. https://doi.org/10.1016/j.jacc.2024.02.042 730. Kassab J, Harb SC, Desai MY, Gillinov AM, Layoun H, El Dahdah J, et al. Incidence, risk factors, and outcomes associated with permanent pacemaker implantation following tricuspid valve surgery. J Am Heart Assoc 2024;13:e032760. https://doi.org/10.1161/ jaha.123.032760 731. Chikwe J, Itagaki S, Anyanwu A, Adams DH. Impact of concomitant tricuspid annuloplasty on tricuspid regurgitation, right ventricular function, and pulmonary artery ESC Guidelines 4729 Downloaded from academic.oup.com/eurheartj/article/46/44/4635/8234488 by guest on 07 October 2026